This policy brief supports and describes an evidence-based and personalized approach to psychotropic deprescribing. The brief additionally outlines that additional research is needed to determine tapering protocols and emphasizes the importance of recognizing that many individuals will still benefit from long-term psychotropic medication treatment. Access this new policy document and use it as a tool in your own advocacy surrounding this important issue.